2024³â 11¿ù 16ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Business

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

WisdomTree Confirms Receipt of Director Nominations from ETFS Capital

WT Consistently Generates Strong Results, Recently Surpassing $90 Billion in Global AUM and Achieving 10th Consecutive Quarter of Net Inflows
´º½ºÀÏÀÚ: 2023-04-13

NEW YORK-- April 13, 2023 -- WisdomTree, Inc. (NYSE: WT) (“WisdomTree” or the “Company”), a global financial innovator, today confirmed receipt of notice from WisdomTree stockholder ETFS Capital Limited (“ETFS Capital”) of its intent to nominate three individuals to stand for election to the Company’s Board of Directors (“Board”) at WisdomTree’s 2023 Annual Meeting of Stockholders (“2023 Annual Meeting”).

Frank Salerno, Chair of the WisdomTree Board of Directors said, “For some time now, we have been engaging with ETFS Capital and its Chairman, Graham Tuckwell, in a good faith effort to avoid a distracting and costly proxy contest. We have met with ETFS Capital multiple times in the past month, and regularly since the beginning of 2022, to try to understand their concerns and intentions. In an effort to take control of WisdomTree, Mr. Tuckwell demanded that our Board agree to replace four incumbent directors with three new directors of his own choosing and one director mutually agreed upon, all while refusing to disclose whom he wished to add. Given WisdomTree’s strong operating results, strong stock performance and recent stock upgrade by UBS, we view this level of wholesale Board change as unjustified and an unwarranted risk to our stockholders. We have completed a significant level of Board refreshment over the past few years, and our current Board members possess extensive experience relevant to WisdomTree’s business strategy, including global financial, accounting and compliance expertise, and many years in senior leadership positions in the investment management and financial services industry.”

Mr. Salerno continued, “Contrary to Mr. Tuckwell’s misleading claims, WisdomTree’s strategy is clearly leading to strong performance results. In fact, we announced yesterday that we have surpassed $90 billion in global AUM for the first time and achieved our 10th consecutive quarter of net inflows. Additionally, WisdomTree stock outperformed the market and was a top performing stock in relation to its identified peer group of traditional asset managers in 2022 and YTD 2023.”

Mr. Salerno concluded, “Despite repeatedly articulating to Mr. Tuckwell our willingness to review possible new directors and consider their suitability and ability to add value to the Board, he refused to identify the director nominees he had in mind. He continued to demand that the Board first agree to the extreme and self-serving ‘framework’ he proposed, asking in effect for a blank check to change the composition of the Board to suit his own preferences. Mr. Tuckwell continues to put his own personal agenda above the interests of all WisdomTree stockholders. Nevertheless, the Board will continue to follow its established protocols to evaluate the Board nominees that ETFS Capital has finally divulged and will continue to, in accordance with our fiduciary duty, act in the best interests of all stockholders.”

The Board and its Nominating and Governance Committee will present the Board’s recommendation regarding director nominees in the Company’s definitive proxy statement, which will be filed with the U.S. Securities and Exchange Commission (“SEC”) and mailed to all WisdomTree stockholders eligible to vote at the 2023 Annual Meeting. The date of the 2023 Annual Meeting has not yet been announced. WisdomTree stockholders are not required to take any action at this time.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Bureau Veritas Strengthens Its Buildings & Infrastructure Leadership Position in Asia-Pacific with an Agreement to Acquire The APP Group
Sandvine Announces Comprehensive Restructuring Transaction as Part of Ongoing Business Realignment
New Data and Recent Approval in China Cements Galderma¡¯s Leadership in Regenerative Biostimulation
Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
Güntner Appoints Michael Bauer as Global Vice President for Growth and Success
The Estée Lauder Companies¡¯ New Incubation Ventures and NYKAA Announce the BEAUTY&YOU India 2024 Winners
Technology Holdings Has Expanded Operations into Brazil, Driving Growth in Latin America

 

Burjeel Holdings and Response Plus Medical launch $1mn Human Energy He...
AngloGold Ashanti Q3 2024 Earnings Release for the Three Months and Ni...
Takeda Announces Strong First Half FY2024 Results and Raises Full Year...
NielsenIQ (NIQ) appoints Steen Lomholt-Thomsen as Chief Commercial Off...
ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
Geopolitical Tensions Reshape Global Competitiveness: Insights from th...
Kinaxis Appoints President of Global Commercial Operations

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚÇ¥±â 'ãæÚ¤ó¢'
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á
¾Ë¶ã°Ç¼³, »óÇ¥µî·Ï ¿Ï·á
Á¸Â÷´åÄÄ, ±Û²Ã º¯°æ »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..